feed,title,long_url,short_url
SeekingAlpha,SAB says NIH discontinuing phase 3 trial of COVID drug SAB-185 as hospitalizations decline,https://seekingalpha.com/news/3808310,
SeekingAlpha,Opthea names seasoned pharmaceutical executive Dr. Joel Naor as CMO,https://seekingalpha.com/news/3808309,
